Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Farmers Insurance
Baxter
Cerilliant
Teva
Argus Health
Mallinckrodt
Cipla
AstraZeneca

Generated: June 18, 2018

DrugPatentWatch Database Preview

Cinoxacin - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for cinoxacin and what is the scope of cinoxacin freedom to operate?

Cinoxacin
is the generic ingredient in two branded drugs marketed by Lilly and Teva, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for cinoxacin.
Summary for cinoxacin
US Patents:0
Tradenames:2
Applicants:2
NDAs:3
Drug Master File Entries: 3
Bulk Api Vendors: 43
Clinical Trials: 1
Patent Applications: 3,704
DailyMed Link:cinoxacin at DailyMed
Medical Subject Heading (MeSH) Categories for cinoxacin
Synonyms for cinoxacin
(1,3)Dioxolo(4,5-g)cinnoline-3-carboxylic acid, 1-ethyl-1,4-dihydro-4-oxo-
(1,3)Dioxolo(4,5-g)cinnoline-3-carboxylic acid, 1,4-dihydro-1-ethyl-4-oxo-
[1,3]Dioxolo[4,5-g]cinnoline-3-carboxylic acid, 1-ethyl-1,4-dihydro-4-oxo-
[1,3]Dioxolo[4,5-g]cinnoline-3-carboxylicacid, 1-ethyl-1,4-dihydro-4-oxo-
[1,5-g]cinnoline-3-carboxylic acid, 1-ethyl-1,4-dihydro-4-oxo-
1-Ethyl-1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid
1-ethyl-1,4-dihydro-4-oxo-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid
1-Ethyl-1,4-dihydro-4-oxo(1,3)dioxolo(4,5-g)cinnoline-3-carboxylic acid
1-Ethyl-1,4-dihydro-4-oxo(1,3)dioxolo(4,5-g)cinnoline-3-carboxylicacid
1-Ethyl-1,4-dihydro-4-oxo[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid
1-ethyl-4-oxidanylidene-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid
1-ethyl-4-oxo-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid
1-Ethyl-4-oxo-1,4-dihydro-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid
1-Ethyl-4-oxo-1,4-dihydro[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid
1-ethyl-4-oxo-1H,4H,7H-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid
1-ethyl-4-oxohydro-7H-1,3-dioxoleno[4,5-g]cinnoline-3-carboxylic acid
1-Ethyl-6,7-methylenedioxy-4(1H)-oxocinnoline-3-carboxylic acid
2323AH
28657-80-9
3B1-003935
5-Ethyl-8-oxo-5,8-dihydro-1,3-dioxa-5,6-diaza-cyclopenta[b]naphthalene-7-carboxylic acid
A819523
AB00051948_17
AB00051948_18
AC1L1EEQ
AC1Q317Y
AK310498
AKOS022507372
Azolinic Acid
BDBM39350
BPBio1_000946
BRD-K14704277-001-05-1
BRN 1084304
BSPBio_000860
BSPBio_002043
C 8645
C08052
C12H10N2O5
CAS-28657-80-9
CCG-39160
CCRIS 8206
CHEBI:3716
CHEMBL1208
cid_2762
Cinobac
Cinobac (TN)
Cinobactin
Cinoxacin (JAN/USP/INN)
Cinoxacin (JP17/USP/INN)
Cinoxacin [USAN:BAN:INN:JAN]
Cinoxacin [USAN:USP:INN:BAN:JAN]
Cinoxacin, United States Pharmacopeia (USP) Reference Standard
Cinoxacine
Cinoxacine [INN-French]
Cinoxacino
Cinoxacino [INN-Spanish]
Cinoxacinum
Cinoxacinum [INN-Latin]
Cinx
Clinoxacin
Compound 64716
CS-4652
CTK1A2019
D00872
D07UXP
DB00827
DivK1c_000318
DR000773
DSSTox_CID_2822
DSSTox_GSID_22822
DSSTox_RID_76745
DTXSID8022822
EINECS 249-133-8
EU-0100309
FT-0602947
HMS1570K22
HMS1920O11
HMS2091E18
HMS2097K22
HMS2235K07
HMS3260N20
HMS3370B19
HMS500P20
HY-B1085
IDI1_000318
J-017182
KBio1_000318
KBio2_000632
KBio2_003200
KBio2_005768
KBio3_001263
KBioGR_000818
KBioSS_000632
Lilly 64716
LMK22VUH23
Lopac-C-8645
Lopac0_000309
LP00309
LS-62687
MCULE-3390574434
MFCD00056776
MLS000069630
MLS001148076
MolPort-001-794-447
NCGC00015277-01
NCGC00015277-02
NCGC00015277-03
NCGC00015277-04
NCGC00015277-05
NCGC00015277-06
NCGC00015277-07
NCGC00015277-08
NCGC00015277-09
NCGC00015277-10
NCGC00015277-11
NCGC00015277-12
NCGC00015277-13
NCGC00015277-14
NCGC00015277-17
NCGC00023754-03
NCGC00023754-04
NCGC00023754-05
NCGC00023754-06
NCGC00023754-07
NCGC00260994-01
NINDS_000318
Noxigram
NSC 304467
NSC-304467
NSC-756695
NSC304467
NSC756695
Opera_ID_1392
Oprea1_131085
Pharmakon1600-01500190
PL053115
Prestwick_239
Prestwick0_000780
Prestwick1_000780
Prestwick2_000780
Prestwick3_000780
PubChem16235
SBB003082
SBI-0050297.P004
SCHEMBL43770
SMR000058232
SPBio_000360
SPBio_002799
Spectrum_000152
SPECTRUM1500190
Spectrum2_000570
Spectrum3_000352
Spectrum4_000289
Spectrum5_000749
SR-01000000129
SR-01000000129-2
ST044511
TNP00246
Tox21_110121
Tox21_110121_1
Tox21_500309
UNII-LMK22VUH23
Uronorm
VDUWPHTZYNWKRN-UHFFFAOYSA-N
ZINC32350

US Patents and Regulatory Information for cinoxacin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva CINOXACIN cinoxacin CAPSULE;ORAL 073005-001 Feb 28, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly CINOBAC cinoxacin CAPSULE;ORAL 018067-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva CINOXACIN cinoxacin CAPSULE;ORAL 073006-001 Feb 28, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly CINOBAC cinoxacin CAPSULE;ORAL 018067-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for cinoxacin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly CINOBAC cinoxacin CAPSULE;ORAL 018067-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Lilly CINOBAC cinoxacin CAPSULE;ORAL 018067-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Johnson and Johnson
Covington
UBS
Mallinckrodt
Fish and Richardson
Federal Trade Commission
Fuji
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.